Hi, How Are You?
Forgot Password?
Sign Up
kalbe_med_lg_white
ID
  • Home
  • Article
  • Events
    All Events Webinar new!
  • Product & Disease
    Product Disease Pharmacovigilance Medical Calculator new!
  • Education
    CPD/CME CDK Multimedia new!
  • Partnership
    HR Customer Partnership new!
  • FAQ & Feedback
  • Login
  • Register
Articles
no_image no_image no_image no_image no_image
Topics
All | COVID-19 | Vitamin & Nutrition | Cancer | Infection Disease | Cardiology
Radiology
Obstetry and Gynecology
Family Medicine
Anesthesiology
Epidemiology
COVID-19
Cancer
Cardiology
Pediatric
Clinical Procedure
Common Diseases
Dental And Oral Health
Dermathology And Aesthetic
Drug
Endocrinology
Eyes
Female
Gastroenterology
General Information
Geriatry
Hematology
Hepatology
Allergy & Immunology
Infection Disease
Inflammation
Male
Mental Health
Mouth Ear Nose
Nephrology
Neurology
Pain
Pathology
Pulmonology
Skeletal & Muscle
Surgery & Recovery
Urology
Vitamin & Nutrition
SPECIAL COVERAGE COVID-19
featured_img
Baricitinib Bermanfaat Menurunkan Mortalitas Pasien COVID-19 Rawat Inap
by dr. Nugroho Nitiyoso, MBA | 29 Juni 2022
Salah satu komponen patogenesis COVID-19 gejala berat adalah terjadinya badai sitokin (cytokine storm), yaitu reaksi imun di mana terjadi peningkatan kadar sitokin pro-inflamasi dalam tubuh pasien. Maka, sebagai pengobatan dari badai sitokin, telah diteliti obat-obatan anti-inflamasi yang bertujuan untuk menurunkan kadar sitokin pro-inflamasi tersebut, misalnya: tocilizumab dan baricitinib.1
Subvarian Baru Omicron BA.4 dan BA.5 Terdeteksi di Indonesia, Ini yang Perlu Diketahui
by dr. Dita Arccinirmala | 14 Juni 2022
6f35c6ab0fbc1113579bb9bceb8bd1a5.jpg
Penggunaan Penghambat DPP4 pada Pasien Diabetes dapat Mengurangi Tingkat Mortalitas COVID-19
by dr. Allen | 06 Juni 2022
fecda1a82c0c74a640e78eaf854028a1.jpg
Latest Articles
    Subscribe Status
    Home
    Article
    Products
    CPD/CME